menu

Tag: asco medical conference

Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Ve...

Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Versus bevacizumab (BE...

  • havensmith

Junshi’s domestic Toripalimab’s significant results in...

Junshi’s domestic Toripalimab’s significant results in recurrent or metasta...

  • havensmith